Bio-Techne’s Advanced Cell Diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.

LightOx Accelerate R&D using A4I – Lifescience Industry News

LightOx, based in Newcastle, has developed a UK-first solution for early-stage mouth cancers using light-activated chemotherapy. The treatment involves a gel being applied to the

July 12, 2023

Review of the Psychedelic Industry in 2023: A Year of Toil, Torment, and Triumph | Psychedelic Invest

2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before 2023

January 19, 2024

Amgen raises ‘bad’ cholesterol concerns in campaign with American Heart Association

Almost half (47%) of heart attack and stroke survivors don’t know their LDL or “bad cholesterol” number. That’s according to a recent American Heart Association

August 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.